Jorge Reyes

Dr. Jorge Reyes


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in PHAGE: Therapy, Applications, and Research
Verified
Journal Article
Closed access
ETEstefanía Tisalema-Guanopatín
Estefanía Tisalema-Guanopatín
Fausto Cabezas-MeraFausto Cabezas-Mera
Fausto Cabezas-Mera
KNKarla Nolivos-Rodríguez
Karla Nolivos-Rodríguez
IFIsabel Fierro
Isabel Fierro
LPLourdes Pazmiño
Lourdes Pazmiño
JRJorge Reyes
Jorge Reyes
Background: Carbapenem-resistant Klebsiella pneumoniae , particularly isolates classified as sequence-type 258 (ST258), are multidrug-resistant strains that are strongly associated with poor-prognosis nosocomial infections, as current therapeutic options are limited and ineffective. In recent years, phage therapy has emerged as a promising treatment option for these scenarios. Methodology and Results: We report the isolation and characterization of three new phages against Klebsiella pneumoniae ST258 strains recovered from Machángara river wastewater. These new members of the Ackermannviridae family showed stability over a wide temperature and pH range and burst sizes ranging from 6 to 44 plaque-forming units per bacteria. Their genomes were about 157 kilobases, with an average guanine-cytosine content of 46.4% and showed presence of several transfer RNAs, which also allowed us to predict in silico a lytic replicative cycle due to the presence of endolysins and lysozymes. Conclusion: Three lytic phages of Ackermannviridae family were recovered against Klebsiella pneumoniae ST258 strains from sewage; however, further characterization is needed for future consideration as therapeutic alternatives.